Trivarx Ltd Market Cap ($8.16 Million)
Market Cap & Net Worth: Trivarx Ltd (TRI)
Trivarx Ltd market cap. Trivarx Ltd (AU:TRI) has a market capitalization of $8.16 Million (AU$11.54 Million) as of November 4, 2026. Listed on the AU stock exchange, this Australia-based company holds position #27446 globally and #1324 in its home market, demonstrating a 25.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Trivarx Ltd's stock price AU$0.01 by its total outstanding shares 1153693464 (1.15 Billion). Also see Trivarx Ltd (TRI) cash conversion ratio for how efficiently the company converts equity into cash flow.
Trivarx Ltd Market Cap History (2015–2026)
Trivarx Ltd market cap history from 2015 to 2026. Data shows change from $4.45 Billion to $8.16 Million (-44.92% CAGR). Check TRI stock price for real-time trading data and today's change.
Trivarx Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Trivarx Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore net asset growth rate of Trivarx Ltd to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
13.74x
Trivarx Ltd's market cap is 13.74 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $5.11 Billion | $23.10K | -$9.79 Million | 221418.34x | N/A |
| 2018 | $333.06 Million | $204.88K | -$16.30 Million | 1625.63x | N/A |
| 2019 | $158.61 Million | $364.63K | -$6.59 Million | 434.99x | N/A |
| 2020 | $130.61 Million | $133.50K | -$4.70 Million | 978.35x | N/A |
| 2021 | $89.79 Million | $101.66K | -$1.49 Million | 883.32x | N/A |
| 2022 | $32.65 Million | $40.04K | -$12.72 Million | 815.54x | N/A |
| 2023 | $24.49 Million | $22.07K | -$3.12 Million | 1109.42x | N/A |
| 2024 | $13.06 Million | $893.31K | -$1.24 Million | 14.62x | N/A |
| 2025 | $15.51 Million | $1.13 Million | -$943.23K | 13.74x | N/A |
Competitor Companies of TRI by Market Capitalization
Companies near Trivarx Ltd in the global market cap rankings as of November 4, 2026. Also see total assets of Trivarx Ltd for a full breakdown of the balance sheet.
Key companies related to Trivarx Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #717 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1658 globally with a market cap of $14.29 Billion USD ( AU$20.19 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2014 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2073 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #717 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $307.00 |
| #1658 | Pro Medicus Ltd | AU:PME | $14.29 Billion | AU$193.27 |
| #2014 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $78.48 |
| #2073 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.26 |
Market Capitalization of Trivarx Ltd (2015–2026)
Market capitalization of Trivarx Ltd from 2015 to today. Between 2015 and today, Trivarx Ltd's market cap moved from $4.45 Billion to $ 8.16 Million, with a yearly change of -44.92%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$8.16 Million | -47.37% |
| 2025 | AU$15.51 Million | +18.75% |
| 2024 | AU$13.06 Million | -46.67% |
| 2023 | AU$24.49 Million | -25.00% |
| 2022 | AU$32.65 Million | -63.64% |
| 2021 | AU$89.79 Million | -31.25% |
| 2020 | AU$130.61 Million | -17.65% |
| 2019 | AU$158.61 Million | -52.38% |
| 2018 | AU$333.06 Million | -93.49% |
| 2017 | AU$5.11 Billion | -10.39% |
| 2016 | AU$5.71 Billion | +28.33% |
| 2015 | AU$4.45 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Trivarx Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $8.16 Million USD |
| MoneyControl | $8.16 Million USD |
| MarketWatch | $8.16 Million USD |
| marketcap.company | $8.16 Million USD |
| Reuters | $8.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Trivarx Ltd
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Med… Read more